Clinical Trial Information
A Phase II Randomized Trial of Radium-223 dichloride and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis (RADICAL)
- Protocol Number: A031801
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Phase: II
- NCT ID: NCT04071223
Scope Information
- Scope:
- National
- Disease Site(s):
- Kidney
